Development of a fluorescence-based enzyme assay of human 5-lipoxygenase
Robert A. Pufahl(Pfizer (United States)), Jaime L. Masferrer(Cyclerion (United States)), Thomas P. Kasten(Monsanto (United States)), Rob Hills(Pfizer (United States)), Robin A. Weinberg(Pfizer (United States)), Beverly A. Reitz(Pfizer (United States)), James K. Gierse(Agricultural Research Service)
Cited by 62
Related Papers
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
|European Journal of Pharmacology|1993|727
Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1B
|Journal of Medicinal Chemistry|2002|467
A Single Amino Acid Difference between Cyclooxygenase-1 (COX-1) and −2 (COX-2) Reverses the Selectivity of COX-2 Specific Inhibitors
|Journal of Biological Chemistry|1996|410
Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase.
|Proceedings of the National Academy of Sciences|1994|243
Analysis of the phosphofructokinase subunits and isoenzymes in human tissues
|Biochemical Journal|1988|157